Apellis Pharmaceuticals (APLS) Stock Price Today & Analysis

APLS
APLS company logo
Loading...
Chart by TradingView

Valuation

Market cap$2.86B
Price-to-sales ratio2.81
Price-to-book value7.12
Price-earnings ratio63.50
Return on Equity19.00%
Return on Sales0.09%
Return on Assets0.05%
PEG ratioN/A

Earnings Per Share

Earnings Per Share$0.35

Income Statement

Average volume3,782,564
EBITDA$93.37M
1 year high (52w)$30.48
1 year low (52w)$16.10

Dividend

Dividend yield0.00%

Solvency

Debt-to-equity ratioN/A

About Apellis Pharmaceuticals

Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. It offers EMPAVELI for the treatment of paroxysmal nocturnal hemoglobinuria, cold agglutinin disease, C3 glomerulopathy and immune complex membranoproliferative glomerulonephritis, amyotrophic lateral sclerosis, and hematopoietic stem cell transplantation-associated thrombotic microangiopathy; and SYFOVRE for treating geographic atrophy (GA). The company has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) for development and commercialization of pegcetacoplan; and a collaboration with Beam Therapeutics Inc. focused on the use of Beam's base editing technology to discover new treatments for complement-driven diseases. The company was incorporated in 2009 and is based in Waltham, Massachusetts.

FAQ

Buying Apellis Pharmaceuticals (APLS) stock is now easy and instant through the Gotrade app.
  1. Download the Gotrade app from the App Store or Google Play.
  2. Create an account and complete KYC.
  3. Make a deposit.
  4. Search for the code "APLS", then tap "Trade".
  5. Tap the "Buy" button.
  6. Enter the amount you want to buy. You have two options:
    1. Buy APLS by number of shares.
    2. Buy fractional shares in dollars, starting from $1.
  7. Swipe up to confirm your order—done!
On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in Apellis Pharmaceuticals from just $1. A small budget shouldn't stop you from building a US stock portfolio.
At the moment, Apellis Pharmaceuticals (APLS) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track APLS's performance via the price chart in the Gotrade app.
Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).
You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours.
Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.
There's no single perfect answer, but common approaches include:
  • Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
  • Review revenue and earnings growth.
  • Check margins and cash flow.
  • Evaluate business outlook and the company's position within its industry.
You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Related news

AppLogo

Buy saham APLS
di Gotrade

AppLogo

Gotrade